|
 |
Pulmicort RespulesThis page contains recent news articles, when available, and an overview of Pulmicort Respules but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Pulmicort Respules (when available) Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease. Mechanism Of Action: The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. News Articles on Budesonide Teva Provides Update on Generic Pulmicort Respules® Launch - Nov 20, 2008 Teva Provides Update on Generic Pulmicort Respules® Launch Business Wire JERUSALEM -- November 20, 2008 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) ... Bloomberg FDA Approves Generic of AstraZeneca Asthma Drug - Nov 19, 2008 Israeli-based Teva said it had begun shipments of Pulmicort Respules immediately after ... Patents covering Pulmicort Respules expire in 2018 with pediatric ... ABC News IVAX to challenge patents protecting AstraZeneca's Pulmicort Respules - Oct 31, 2005 LONDON (AFX) - IVAX Corp said it is challenging the patents protecting AstraZeneca's Pulmicort Respules (budesonide inhalation suspension) for use in the ... Forbes … Daily Treatment With PULMICORT RESPULES(R) Significantly Increased … - Nov 14, 2006 Children treated with PULMICORT RESPULES(R) (budesonide inhalation suspension) either once or twice daily experienced a significantly greater increase in ... Medical News Today - Medical News Today (press release) Article: State: Medicaid limiting access to drugs. - St. Petersburg... - Jul 19, 2005 Administration's approval of AstraZeneca's Pulmicort Respules(TM) (budesonide inhalation ... Article: AstraZeneca Settles US Pulmicort Respules Patent ... ... Pay-Per-View - St. Petersburg Times - HighBeam Research AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva - Nov 25, 2008 WILMINGTON, Del., Nov. 25 /PRNewswire-FirstCall/ -- AstraZeneca todayannounced it has entered into a settlement agreement in its Pulmicort Respulespatent ... International Business Times Article: Medicaid puts kids' drug back on its list. - St. Petersburg... - Jul 20, 2005 The medicine, Pulmicort Respules, apparently was taken off Medicaid's list of ... FDA approval of Pulmicort Respules is based on data ... persistent asthma. ... Pay-Per-View - St. Petersburg Times - HighBeam Research Pulmicort Respules.(Drug overview) - Jan 22, 2007 Budesonide, the active ingredient in Pulmicort Respules, is an anti-inflammatory steroid medication. Inhaled on a regular basis, Pulmicort helps prevent ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com … the Long-Term Use of PULMICORT RESPULES Is Well-Tolerated in … - Nov 8, 2005 ANAHEIM, Calif., Nov. 8 /PRNewswire-FirstCall/ -- Long-term treatment with PULMICORT RESPULES(R) (budesonide inhalation suspension), ... RedOrbit … Denies Teva's Motion For Summary Judgment In Pulmicort Respules … - Sep 24, 2008 The FDA has not approved a generic form of PULMICORT RESPULES, and has not yet ... PULMICORT RESPULES is a preventive, maintenance asthma medicine indicated ... webwire.com … Release: Once- or Twice-Daily Treatment With PULMICORT RESPULES( … - Nov 13, 2006 Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) (budesonide inhalation suspension) Significantly Increased Percentage of Days Asthma Is ... Pay-Per-View - PR Newswire - HighBeam Research … Agreement On Generic Pulmicort Respules(R) Patent Challenge - Nov 27, 2008 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with ... Medical News Today - Medical News Today (press release) Study shows adherence to pulmicort respules, results in fewer ER... - May 24, 2005 San Diego, Calif. ñ May 24, 2005 ñ Young children who are adherent with asthma controller therapies overall, and specifically PULMICORT RESPULESÆ ... PsychCentral.com Adherence to pulmicort respules, results in fewer ER visits in... - May 26, 2005 Young children who are adherent with asthma controller therapies overall, and specifically PULMICORT RESPULES® (budesonide inhalation suspension), ... i-newswire.com … : AstraZeneca Settles US Pulmicort Respules Patent Litigation with... - Nov 25, 2008 AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Article: Correction.(PEOPLE BUSINESS)(Correction notice) - Medical … - Apr 1, 2006 Administration's approval of AstraZeneca's Pulmicort Respules(TM) (budesonide inhalation ... Article: AstraZeneca Settles US Pulmicort Respules Patent ... ... Pay-Per-View - Medical Marketing & Media - HighBeam Research … : Study Showed Adherence to PULMICORT RESPULES(R) Results in … - May 24, 2005 Study Showed Adherence to PULMICORT RESPULES(R) Results in Fewer ER Visits and Hospitalizations in Asthmatic Children. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Is Your Medicine The Real Deal? - Jan 8, 2007 But, as part of a settlement, it had to place a disclosure on its site that says it does not sell Pulmicort Respules and that the compounded version has not ... BusinessWeek State: Medicaid limiting access to drugs. - Jul 19, 2005 That medicine, Pulmicort Respules, apparently was dropped mistakenly from ... Removing Pulmicort Respules from that list is a special problem because it's ... Free with registration - St. Petersburg Times - AccessMyLibrary.com AstraZeneca asthma drug faces US patent crunch - Sep 22, 2008 Full-year US sales for Pulmicort in 2007 totalled $964 million and about 90 percent of this was accounted for by Pulmicort Respules, the form of the drug ... Reuters … for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation. … - Sep 23, 2008 The FDA has not approved a generic form of PULMICORT RESPULES, ... Administration's approval of AstraZeneca's Pulmicort Respules(TM) (budesonide inhalation ... Pay-Per-View - PR Newswire - HighBeam Research FDA Safety Labeling Changes: Hectorol, Mevacor, Pulmicort Respules - Sep 28, 2005 Sept. 28, 2005 ( updated Oct. 6, 2005) -- The US Food and Drug Administration (FDA) approved safety labeling revisions in June to advise that ... Medscape Press Release: Par Pharmaceutical Halts Shipment of Budesonide … - Nov 20, 2008 This action does not effect sales of branded Pulmicort Respules ... Administration's approval of AstraZeneca's Pulmicort Respules(TM) (budesonide inhalation ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Study Indicated That Early Use of Nebulized Inhaled … - Mar 21, 2005 Pulmicort Respules is approved ... to treat an asthma attack. The FDA approval of Pulmicort Respules is based on ... persistent asthma. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Review Article Indicated That Optimal Device Choice... - Nov 10, 2005 The review stated that nebulized therapy, such as PULMICORT RESPULES, ... PULMICORT RESPULES is indicated in children 12 months to eight years of age. ... Pay-Per-View - PR Newswire - HighBeam Research Tel Aviv higher; Teva forms Japan venture, loses legal round - … - Sep 24, 2008 AstraZeneca said it's confident of the strength of the intellectual property protecting Pulmicort Respules. Within the real-estate companies, ... MarketWatch Asthma; Pulmicort Respules well-tolerated in children with severe... - Dec 6, 2005 2005 DEC 6 - (NewsRx.com) -- Long-term treatment with Pulmicort Respules (budesonide inhalation suspension), a product of AstraZeneca Pharmaceuticals, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones MAP Pharmaceuticals, AstraZeneca partner on asthma drug - Dec 19, 2008 Teva came out with a generic version of Pulmicort Respules, and conceded that its generic infringes AstraZeneca's patents. The settlement prevents Teva from ... Bizjournals.com Steroids, inhaled.(Drug overview) - May 24, 2006 The product name is Pulmicort Turbuhaler and Pulmicort Respules. ... Pulmicort Respules are delivered with a nebulizer using either a mouthpiece or a ... $4.95 - Clinical Reference Systems - ECNext Press Release: Par Pharmaceutical Begins Shipment of Budesonide … - Nov 19, 2008 Pulmicort Respules About Par Pharmaceutical Par Pharmaceutical, ... PULMICORT RESPULES(R) (budesonide inhalation suspension) is a product of AstraZeneca . ... Pay-Per-View - PR Newswire - HighBeam Research Review Article Indicated That Optimal Device Choice for Pediatric... - Nov 10, 2005 The review stated that nebulized therapy, such as PULMICORT RESPULES, ... PULMICORT RESPULES is indicated in children 12 months to eight years of age. ... $4.95 - PR Newswire - ECNext The tools of engagement: while the evolution of Web-based technology ... - Jun 1, 2005 Everydaykidz.com is more than a Web site, insists the Pulmicort Respules team. ... Vic Noble, Pulmicort Respules senior consumer pro motions manager, says, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Use of inhaled corticosteroid led to fewer hospitalizations for young... - Mar 21, 2005 Pulmicort Respules uses a nebulizer to deliver the medication to children, ... Pulmicort Respules is not a quick-relief medicine (bronchodilator) and should ... PsychCentral.com The tools of engagement: while the evolution of Web-based technology ... - Jun 1, 2005 Everydaykidz.com is more than a Web site, insists the Pulmicort Respules team. ... Vic Noble, Pulmicort Respules senior consumer pro motions manager, says, ... $9.94 - Medical Marketing & Media - Alacra Store Article: New Long-Term Tolerability Data for Pulmicort(R) Strengthens... - Jan 24, 2005 Budesonide (Pulmicort Respules, Pulmicort Turbuhaler) is available as a DPI (Pulmicort ... Studies have shown that Pulmicort Respules is safe and effective ... Pay-Per-View - PR Newswire Europe - HighBeam Research Astra dumped as pipeline disappoints. | Article from Investors... - Nov 20, 2008 Astra estimates that the generic launch of Pulmicort Respules will reduce EPS by $0.16 after Israel's Teva Pharmaceutical Industries gained US regulatory ... Pay-Per-View - Investors Chronicle - magazine and web... - HighBeam Research Senden wins for charity at John Deere Classic - Jul 15, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Budesonide can cause systemic problems in young infants AAP Priority ... - Feb 2, 2005 Furthermore, you find that Pulmicort Respules is indicated for asthmatic patients 12 months to 8 years of age but is not labeled for use in younger patients ... AAP News - AAP News (subscription) Medicaid will fix error on asthma drug; Kids' medicine added back to ... - Jul 21, 2005 The medicine, Pulmicort Respules, apparently was taken off Medicaid's list of preferred drugs by ... Pulmicort Respules are vials of liquid medicine. ... Pay-Per-View - Tallahassee Democrat - Factiva, from Dow Jones Press Release: Cadient Group Recognized with Five Awards at 14th … - Jun 18, 2008 Pulmicort Respules - Silver Communicator Award Cadient Group's Pulmicort Respules ... For this branded Web site for AstraZeneca's Pulmicort Respules, ... Pay-Per-View - PR Newswire - HighBeam Research Woods wins for charity at Buick Open - Aug 5, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Appleby wins for charity at Shell Houston Open - Apr 22, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Largest Ever Asthma Trial Highlights Safety Of Pulmicort Treatment … - Dec 17, 2005 Both Pulmicort Turbuhaler and Pulmicort Respules are the only inhaled corticosteroids to be given a category B pregnancy rating by the United States Food ... Medical News Today - Medical News Today (press release) PGA TOUR: Donald, Mayfair win for charity at The Honda Classic - Mar 12, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... noticias.info Curtis wins for charity at Booz Allen Classic - Jun 24, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour AstraZeneca выиграла у Teva первый раунд борьбы против выпуÑ?ка … - Nov 20, 2008 Срок дейÑ?твиÑ? патентов на Pulmicort Respules иÑ?текают в 2018 г., ... Ð’ 2007 г. объем продаж Pulmicort Respules в СШÐ? Ñ?оÑ?тавил 964 млн долл. СШÐ?. ... ФармацевтичеÑ?кий веÑ?тник Inhaled corticosteroids for long-term control of asthma - Mar 22, 2007 Budesonide (Pulmicort Respules) for use with a nebulizer is approved for use in children ages 1 to 8. However, the nebulized medication is more expensive ... MSN Health & Fitness ASTRAZENECA: DEUTSCHE BANK HÖJER RIKTKURSEN TILL 2.700 … - Nov 26, 2008 Pulmicort Respules skyddades av det sÃ¥ kallade användarpatentet som enligt vÃ¥r mening är svagare än substanspatent", heter det i analysen. ... Dagens Nyheter Curtis, Howell III win for charity at 84 LUMBER Classic - Sep 16, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY … - Feb 19, 2007 Depakote 542016 -3.8 70 Combivent 534477 6.6 71 Humalog 533683 10.1 72 Geodon Oral 529350 24.8 73 Pulmicort Respules 520747 7.1 74 Trileptal 513429 12.0 ... Free with registration - Drug Topics - AccessMyLibrary.com Love III, Couch win for charity at Chrysler Classic of Greensboro - Oct 7, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour AstraZeneca и Teva урегулировали патентный Ñ?пор в отношении … - Nov 26, 2008 Ð?апомним, что Teva начала поÑ?тавки непатентованного аналога Pulmicort Respules 19 ноÑ?брÑ?, Ñ?разу поÑ?ле получениÑ? одобрениÑ? FDA и неÑ?мотрÑ? на продолжающийÑ?Ñ? ... ФармацевтичеÑ?кий веÑ?тник Basal and Cosyntropin-Stimulated Plasma Cortisol Concentrations, as … - Mar 13, 2007 ...were treated with budesonide inhalation suspension (Pulmicort Respules; AstraZeneca LP, Wilmington, DE; two doses: 0.5 and 1.0 mg) or matching placebo. ... Journal of Clinical Endocrinology and... Henry wins for charity at Buick Championship - Jul 1, 2006 ...that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. ... PGA Tour Europe sees mixed finish - MarketWatch - Nov 26, 2008 AstraZeneca shares advanced 0.6% with investors taking on board news that the drugmaker has settled its Pulmicort Respules US patent litigation with Teva ... MarketWatch Drug companies trigger European ire for holding back supplies of... - Nov 29, 2008 ...largest generic drugs producer, which threatened to start making a generic version of Pulmicort Respules, its billion-dollar-selling asthma treatment. ... Times Online Safety concerns grow over pharmacy-mixed drugs - Mar 23, 2005 She called the pharmacy and was told the drug wasn't Pulmicort Respules, the brand-name drug made by AstraZeneca that her son had been taking. ... USA Today Sanofi Cuts Deal In Legal Battle And Redeploys - Nov 20, 2008 ...mixed results from a late-stage cancer drug trial and said rival Teva has gained approval for a generic version of its asthma drug Pulmicort Respules. ... Forbes Indica estudio que el uso temprano de los corticosteroides inhalados ... - Mar 21, 2005 Pulmicort Respules es una medicina preventiva. Pulmicort Respules no es medicina de alivio rápido (broncodilatador) y NO debe emplearse para el tratamiento ... businesswire.com Market update - 26 November - Nov 26, 2008 Investors bought in after the pharma group said it had settled the Pulmicort Respules patent infringement case against Iva Pharmaceuticals. ... Independent UK Stocks - Factors to watch on Nov 26 - Nov 26, 2008 ...on Tuesday they have reached a settlement in their patent infringement dispute over AstraZeneca's Pulmicort Respules asthma medicine. [ID:nN2529857] ... Reuters Drug/Medical Device Report Tanox, Inc. (TNOX) - Aug 4, 2007 AstraZeneca plc (ADR) (AZN) / Pulmicort Respules. (Budesonide). -. Sepracor Inc. (SEPR) / Xopenex (Levalbuterol. Hydrochloride) ... $70.00 - Revere Reports - Revere AstraZeneca: fin du litige avec et Teva sur un anti-asthmatique - Nov 26, 2008 ...en fait l'un des ses médicaments-vedette. Selon AstraZeneca, le Pulmicort Respules dispose d'un brevet d'exclusivité en matière pédiatrique jusqu'en 2019. radio rottu oberwallis FDA warns manufacturers of compounded drugs: traditional … - Oct 1, 2006 ...which are similar to the 0.5-mg and 0.25-mg strengths of Pulmicort Respules. The letter says the FDA had determined that the company was operating as a ... Free with registration - Internal Medicine News - AccessMyLibrary.com Teva raided in EU antitrust probe - Nov 27, 2008 On Tuesday, they agreed to delay selling any more versions of AstraZeneca's Pulmicort Respules asthma medicine until December 2009. Jerusalem Post Steroids, inhaled.(Pediatric Advisor 2007)(Drug overview) - May 31, 2007 Pulmicort Respules are delivered with a nebulizer using either a mouthpiece or a properly fitted mask to avoid getting the medicine in the eyes. ... $4.95 - Clinical Reference Systems - ECNext United States top 200 brand-name pharmaceuticals by retail sales in … - Feb 19, 2007 Depakote 542016 -3.8 70 Combivent 534477 6.6 71 Humalog 533683 10.1 72 Geodon Oral 529350 24.8 73 Pulmicort Respules 520747 7.1 74 Trileptal 513429 12.0 ... $20.00 - Drug Topics - Alacra Store UK Stocks Decline on Recession Concern; Shell, HSBC Slide - Nov 19, 2008 ...granted approval for a generic version of the Pulmicort Respules asthma drug, rejecting some of the UK drugmaker's arguments put in a citizen's petition. Bloomberg A warning on asthma drugs, Mass-marketed drug compounds sold for … - Mar 14, 2006 ...and Warrick Pharmaceuticals; Xopenex, a product of Sepracor Inc.; DuoNeb by Dey LP; and Pulmicort Respules, manufactured by AstraZeneca, Sander said. ... Pay-Per-View - Newsday - ProQuest Archiver Top 200 brand name drugs by units in 2006.(COMMUNITY PRACTICE)( … - Mar 5, 2007 1/35 2442 -3.4 122 Atacand 2393 3.3 123 Lanoxin 2389 -32.1 124 Pulmicort Respules 2389 -0.7 125 Tobradex 2371 1.2 126 Trivora-28 2348 -10.7 127 Alphagan ... $4.95 - Drug Topics - ECNext Bristol-Myers, Deutsche Bank, Chevron in Court News - Nov 26, 2008 AstraZeneca Plc settled a patent dispute over generic forms of Pulmicort Respules and said it will get “significantâ€? royalties from copies by Teva ... Bloomberg Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY … - Feb 19, 2007 Depakote 542016 -3.8 70 Combivent 534477 6.6 71 Humalog 533683 10.1 72 Geodon Oral 529350 24.8 73 Pulmicort Respules 520747 7.1 74 Trileptal 513429 12.0 ... $4.95 - Drug Topics - ECNext NEW JERSEY BRIEFS | Article from The Record (Bergen County, NJ) | … - Nov 21, 2008 The drug maker won a temporary restraining order preventing Israel's Teva Pharmaceutical Industries Ltd. from selling a copy of the Pulmicort Respules ... Pay-Per-View - The Record - HighBeam Research Article: New generics ready for market.(RX RETAIL PHARMACY: Generic … - Jul 23, 2007 ...barring privately held, Canada-based Apotex Corp. from selling a generic version of AstraZeneca PLC's Pulmicort Respules, an asthma medication. ... Pay-Per-View - Chain Drug Review - HighBeam Research FDA warns 3 compounders of inhalation drugs.(Clinical Rounds) - Sep 1, 2006 ...which are similar to the 0.5-mg and 0.25-mg strengths of Pulmicort Respules. The letter says the FDA had determined that the company was operating as a ... Free with registration - Pediatric News - AccessMyLibrary.com ASTRAZENECA: PULMICORT-PATENT FÖRLORAS SANNOLIKT - … - Sep 24, 2008 STOCKHOLM (Direkt) Deutsche Bank tror fortsatt att Astrazeneca kommer att förlora patenttvisten med Teva Pharmaceutical, angÃ¥ende Pulmicort Respules i USA. ... Dagens Nyheter Astrazeneca Announces First Regulatory Approval For New HFA PMDI … - Feb 15, 2006 Pulmicort is available in three administration forms, a dry powder inhaler (Pulmicort Turbuhaler), as a nebulising suspension (Pulmicort Respules) and as a ... Medical News Today - Medical News Today (press release) Posting solid 2nd-qtr results, AstraZeneca announces another cost... - Aug 6, 2007 ...helped by a 7% rise in the USA - chiefly as a result of the performance of Pulmicort Respules (an inhaler form for young childen), which increased 23%. ... $9.94 - Pharma Marketletter - Alacra Store Baddeley, Furyk win for charity at Verizon Heritage - Apr 15, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Matteson wins for charity at FUNAI Classic at WALT DISNEY WORLD … - Oct 21, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Oberholser, Weir win for charity at AT&T Pebble Beach National Pro-Am - Feb 11, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Q3 2005 Ivax Earnings Conference Call - Final. - Nov 8, 2005 The newest addition to our list of potential first to file generic opportunities is our generic version of Pulmicort Respules, AstraZeneca's asthma ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com New Studies Reveal What Caregivers See as Key Issues to Facilitate … - Nov 13, 2006 Through innovative respiratory products, including SYMBICORT(R), PULMICORT RESPULES(R), PULMICORT TURBUHALER(R), and RHINOCORT AQUA(R), AstraZeneca is ... Free with registration - PR Newswire - AccessMyLibrary.com Pettersson wins for charity at the Memorial Tournament - Jun 4, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour MAP shares rise on revenue boon from partnership - Dec 22, 2008 ..."This is a very positive development for MAP given AstraZeneca's expertise and leadership in this market with its blockbuster drug Pulmicort Respules," ... International Business Times Choi wins for charity at the Chrysler Championship - Oct 28, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Kaiser Daily Health Policy Report Highlights News Coverage of … - Jul 23, 2005 Florida: Florida's Medicaid program will begin covering the asthma medication Pulmicort Respules for children ages five years and under, reversing an error ... Medical News Today - Medical News Today (press release) FDA warns compounders of inhaled budesonide.(News) - Sep 15, 2006 ...which are similar to the 0.5-mg and 0.25-mg strengths of Pulmicort Respules. The letter says the FDA had determined that the company was operating as a ... Free with registration - Family Practice News - AccessMyLibrary.com PARI Celebrates 100 Years of Aerosol Therapy. - May 17, 2006 PARI products for inclusion in their clinical trials and regulatory approval process including Pulmicort Respules by AstraZeneca; Xopenex by Sepracor; ... Free with registration - PR Newswire - AccessMyLibrary.com Event Brief of Q3 2005 Ivax Earnings Conference Call - Final. - Nov 8, 2005 The newest addition to the list of potential first-to-file generic opportunities is the generic version of Pulmicort Respules, AstraZeneca's asthma ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com AstaZeneca gives $7M to American Cancer Society - Dec 22, 2006 The firm has a facility in Westborough where it manufactures the Pulmicort Respules asthma medicine for children and an injectable version of the ... wickedlocal.com 2009's Generic Drugs: Who's at Risk - Dec 30, 2008 ...allowing Teva to launch generic versions of AstraZeneca's asthma treatment Pulmicort Respules next year, 10 years before the patent expires. ... fool.com FDA warns firms to stop making knockoffs of inhalation meds - Dec 12, 2006 Since at this time there are no FDA-approved generic forms of Pulmicort Respules, Xopenex or DuoNeb, any generic substitution for these medications is an ... AAP News - AAP News (subscription) Herron, Pampling win for charity at Bank of America Colonial - May 20, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour AstraZeneca tours for pediatric asthma.(DIRECT MARKETING) - Oct 1, 2005 ...direct marketing tour to raise awareness of pediatric asthma and to promote its asthma drug Pulmicort Respules and its Web site, www.everydaykidz.com. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Scott wins for charity at THE TOUR Championship presented by Coca- … - Nov 4, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour Top 200 brand-name drugs by units in 2005.(rankings ) - Mar 20, 2006 Cosopt 2506 4.2 125 Elidel 2463 -35.7 126 Vivelle-DOT 2449 10.2 127 Proscar 2429 -3.8 128 Cefzil 2411 -13.3 129 Pulmicort Respules 2406 2.8 130 Thyroid, ... Free with registration - Drug Topics - AccessMyLibrary.com Furyk wins for charity at Wachovia Championship - May 6, 2006 NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, ... PGA Tour The Right Fit: Choosing the Best Nebulizer for Your Patient - Jan 2, 2008 It cannot be used with all drugs, however, particularly suspensions such as Pulmicort Respules, a pediatric asthma medication. ... news Stories Vital signs. - May 1, 2006 Zyrtec Syrup 2353 Zyrtec 1895 Advair Diskus 1559 Pulmicort Respules 1334 Zithromax Z-Pak 1275 Note: Estimated data based on prescription drugs dispensed ... Free with registration - Pediatric News - AccessMyLibrary.com Brand Names/Synonyms: Pulmicort Respules is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon Drug Category: Pulmicort Respules is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 Dosage Forms: CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION Absorption: Complete Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |